HbA1c | Group A HbA1c ≤7.2 % | Group B 7.2 % <HbA1c ≤8.2 % | Group C 8.2 % <HbA1c ≤9.2 % | Group D HbA1c >9.2 % | P value |
---|---|---|---|---|---|
Males /femalesa | 5/19 | 8/18 | 10/17 | 9/15 | 0.518 |
Age (years)b | 36.5 (32.0–58.8) | 41.5 (31.5–54.5) | 41.0 (32.0–55.0) | 42.0 (35.0–57.8) | 0.956 |
Duration of diabetes (years)b | 11.0 (5.3–30.0) | 15.0 (7.8–25.5) | 15.0 (5.0–24.0) | 10.5 (7.3–15.0) | 0.653 |
BMI (kg/m2)b | 20.3 (18.2–22.3) | 22.6 (21.0–24.9) | 22.4 (20.0–23.8) | 22.2 (20.3–25.3) | 0.007 |
U-CPR (µg/day)b | 1.2 (0.9–3.9) | 0.9 (0.6–2.6) | 1.3 (0.7–3.6) | 1.0 (0.5–6.0) | 0.622 |
Total daily dose of insulin (units)b | 31.0 (25.5–38.8) | 35.0 (26.5–41.5) | 37.0 (29.0–46.0) | 39.0 (31.3–51.5) | 0.099 |
Basal insulin dose (units)b | 13.5 (9.3–19.5) | 14.0 (10.0–20.3) | 15.0 (12.0–18.0) | 18.5 (14.0–24.8) | 0.021 |
Bolus insulin dose (units)b | 17.0 (15.0–24.0) | 19.5 (15.0–24.3) | 20.0 (16.0–30.0) | 21.5 (13.8–27.5) | 0.296 |